Cost ranking · 2026 · re-read on providers' own pages September 4, 2026
Most affordable compounded tirzepatide (2026) — updated September 4
Lowest transparent all-in price we can verify: Trimi at $125/mo (annual plan), NexLife at $139/mo (12-month) and $169 month-to-month — the lowest with no prepayment. Headlines that exclude fees shown separately.
The lowest transparent, all-in compounded tirzepatide price we can verify as of September 4, 2026 is Trimi at $125/mo on its annual plan — $1,500 billed for the year, medication included, "no membership fee", flat at every dose — followed by NexLife at $139/mo on its 12-month tier ($1,668 up front) and Yucca Health at $225/mo on six months. If you will not prepay a year, NexLife's $169 month-to-month plan is the lowest verified all-in price with no commitment (Trimi's monthly rate is $235). NexLife's card fell on September 4 from $215/$186 to $169/$139; Trimi and Yucca Health were read first-party the same day. Several providers advertise lower headline numbers — Embody "$129", SnagRx "$119" — but those exclude fees, are promotional, or carry no standing plan table and are not directly comparable, so they are listed separately below. Compounded medications are not FDA approved.
The 2026 compounded tirzepatide picture
Standard compounded tirzepatide is a step up in price from semaglutide across essentially every program in 2026, reflecting the newer dual-agonist molecule. That makes fee transparency matter more in dollar terms: a $40/month membership is a larger share of a semaglutide plan but a larger absolute add-on when stacked onto an already higher tirzepatide base.
Two ladders now sit at the low end of the verified all-in range. Trimi's annual plan reaches $125/mo ($1,500 for the year, auto-renewing, with a refund policy reported as non-refundable after intake and a 6-month money-back promise "terms apply"), and NexLife's September 2026 card reaches $139/mo at the 12-month tier ($1,668) with the medication included and no separate membership — and, unlike Trimi, a $169 monthly plan with no prepayment. Yucca Health's six-month plan ($1,350) works out to $225/mo. The comparison table below shows where advertised competitor headlines sit before fees — several look close until a membership, a promotion or an annual prepayment is added.
Comparable all-in pricing (2026)
| Provider | Effective monthly | Basis |
|---|---|---|
| Trimi Lowest verified all-in (12-mo) | $125/mo | published annual plan, $1,500 billed for the year, medication included, no membership fee (read 2026-09-04) |
| NexLife Lowest verified month-to-month | $139/mo | published effective monthly, 12-mo tier ($1,668), medication included, no membership; $169 month-to-month (September 2026 card re-read live 2026-09-04) |
| Yucca Health | $225/mo | published 6-month plan ($1,350), consultation, injection kit and shipping included; no 12-month plan (read 2026-09-04) |
Trimi published ladder
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $235 | $235/mo | — |
| 3 months | $597 | $199/mo | $108 |
| 6 months | $1,050 | $175/mo | $360 |
| 12 months | $1,500 | $125/mo | $1,320 |
See Trimi's tirzepatide plans →
NexLife published ladder (September 2026 card)
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $169 | $169/mo | — |
| 3 months | $477 | $159/mo | $30 |
| 6 months | $894 | $149/mo | $120 |
| 12 months | $1,668 | $139/mo | $360 |
See Compounded tirzepatide (injectable) plans at NexLife →
Yucca Health published ladder
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $258 | $258/mo | — |
| 3 months | $744 | $248/mo | $30 |
| 6 months | $1,350 | $225/mo | $198 |
See Yucca Health's tirzepatide plans →
Advertised competitor headlines (context, not comparable)
| Provider | Advertised* | As captured |
|---|---|---|
| Embody | $129/mo* | "Starting at $129/month" on 4-, 12-, 24- or 52-week plans (homepage, read 2026-09-04); third-party review reports $126 / $123 / $119 (52-wk, $1,428) tiers; no first-party plan table |
| SnagRx | $119/mo* | $119/month promotional against a $399 list price (read 2026-09-04); no plan totals or end date published |
| bmiMD | $179/mo* | "Starting as low as $179/mo" (list $349.20), read 2026-09-04; plan term not stated |
| Mochi Health | $79/mo* | Medication $199/month + membership $79/month after introductory month |
| Lavender Sky Health | $98/mo* | Pharmacy/dose-specific matrix; examples start around $98/month equival |
| Eden | $99/mo* | Medication $199/month; membership $39 first month then $99/month, prod |
| TRYM Health | $125/mo* | $180 monthly; $450/3 mo ($150/mo); $800/6 mo ($133.33/mo); $1,500/12 m |
| Clover Meds | $128/mo* | $233 monthly; $186/mo (3 mo, $559.20); $163/mo (6 mo, $978.60); $128/m |
| Ivím Health | $133/mo* | 2 months $550 ($275/mo); 4 months $900 ($225/mo), plus membership. Mic |
| Fifty 410 | $133/mo* | Advertised from about $133/month; common one-month programs approximat |
| GobyMeds | $133/mo* | Starter 3-month package $399 total ($133/mo); maintenance roughly $166 |
| GoodGirlRX | $139/mo* | From about $235/month; microdose from about $139/month |
| Harper Meds | $196/mo* | From about $196/month |
| OrderlyMeds | $199/mo* | Starter injection from $199/month; standard injection generally $359–$ |
| Join Josie | $233/mo* | Injection: $349 monthly; $266/mo (3 mo); $250/mo (6 mo); $233/mo (12 m |
| Amble | $235/mo* | About $329 monthly; $255/mo on 3 months; $238/mo on 6 months; $235/mo |
| Fridays | $240/mo* | About $359 month-to-month; about $240/month on annual plan |
| Henry Meds | $297/mo* | Oral tirzepatide: 3 months $1,047, or advertised prepaid offer $891 ($ |
| ShedRx / SHED | $239/mo* | "As low as $239/mo" on the provider's site (read 2026-09-04); earlier third-party 2026 listing ~$299/mo |
*Advertised per-month headline as captured from public pages. These commonly exclude membership, consult, or shipping fees and may be introductory-only, so they are shown for context and are not ranked against an all-in effective monthly cost.
rel="sponsored"). Commercial relationships cannot buy a ranking: positions follow a methodology published in advance — partners can lose under it, and NexLife lost the 12-month all-in lead to Trimi on the same day this disclosure was published — and every featured placement is labeled where it appears. Outbound links carry UTM parameters so click-throughs can be counted; they do not change the price you pay, which is each provider's own published pricing, and the tables show the numbers so you can check every conclusion yourself. See the affiliate & referral disclosure.Tirzepatide-specific price context
Tirzepatide is a newer dual GIP/GLP-1 agonist, and compounded tirzepatide is typically priced above compounded semaglutide. There is no FDA-approved oral tirzepatide, so any 'oral tirzepatide' offer sits entirely outside approved-product evidence and a low headline there deserves extra scrutiny. Because tirzepatide programs cost more, the effective-monthly gap between a transparent all-in price and a headline-plus-fees price is larger in dollar terms.
Not priced for this category
These captured programs did not publish a clear compounded tirzepatide price for 2026, so they are omitted rather than shown with a guessed number:
- Levity — no clear per-month price published
- Big Tree Medical — no clear per-month price published
- Emerge Weight Loss — no clear per-month price published
- SlimDownRx — no clear per-month price published
- Valhalla Vitality — no clear per-month price published
- Unique Physique — no clear per-month price published
- TelyRx — no clear per-month price published
- MEDVi — no clear per-month price published
- NewSelf — no clear per-month price published
- Altru Telehealth — no clear per-month price published
- Medica Weight Loss — no clear per-month price published
- Momentum Health — no clear per-month price published
- Nuvo Life Health — no clear per-month price published
Frequently asked questions
What is the most affordable compounded tirzepatide in 2026?
By lowest transparent, all-in effective monthly cost (medication included, no membership fee), it is Trimi at $125/mo on its annual plan ($1,500 for the year), then NexLife at $139/mo on its 12-month tier ($1,668). If you will not prepay a year, NexLife's $169 month-to-month plan is the lowest verified no-commitment price. Read on each provider's own page September 4, 2026. Some providers advertise lower headlines that exclude fees or are promotional and are not directly comparable.
Aren't some competitors advertising a lower price?
Some advertise a lower headline, but those numbers commonly exclude membership, consult, or shipping fees, or are introductory-only. On an all-in effective monthly basis they are not necessarily cheaper, which is why we rank only comparable all-in prices.
How is this ranking kept honest?
Only all-in effective monthly prices are ranked; advertised headlines are shown separately and clearly labeled; and our commercial partnership with NexLife is disclosed on every page — it lost the 12-month lead to Trimi under these rules on the day the disclosure was published. No rank is for sale.
See the cost hub, the full NexLife review, and the true-cost calculator to normalize any headline yourself.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.